We are live on ! Find out more
WVE icon

Wave Life Sciences
WVE

49 hedge funds and large institutions have $432M invested in Wave Life Sciences in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 13

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

11% more capital invested

Capital invested by funds: $388M → $432M (+$43.5M)

3.61% more ownership

Funds ownership: 63.13% → 66.74% (+3.6%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

4% less funds holding

Funds holding: 51 → 49 (-2)

Holders
49
Holders Change
-2
Holders Change %
-3.92%
% of All Funds
1.22%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
7
Increased
19
Reduced
13
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$9.61M
2
BlackRock
BlackRock
New York
+$9.38M
3
RG
Redmile Group
California
+$8.92M
4
CCP
Clough Capital Partners
Massachusetts
+$5.5M
5
OM
Opaleye Management
Massachusetts
+$2.19M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.75M
2
Marshall Wace
Marshall Wace
United Kingdom
-$780K
3
CAM
Cormorant Asset Management
Massachusetts
-$721K
4
Renaissance Technologies
Renaissance Technologies
New York
-$403K
5
Morgan Stanley
Morgan Stanley
New York
-$318K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$195M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$49.4M -$2.75M -98,307 -5%
RG
3
Redmile Group
California
$35M +$8.92M +319,385 +34%
FCMI
4
Foresite Capital Management III
California
$18.6M – – –
PA
5
Perceptive Advisors
New York
$18.3M – – –
NLVP
6
New Leaf Venture Partners
New York
$18.1M – – –
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$13.4M +$9.61M +344,040 +242%
CAM
8
Cormorant Asset Management
Massachusetts
$13.3M -$721K -25,828 -5%
DM
9
Deerfield Management
New York
$13M – – –
EAM
10
Eventide Asset Management
Massachusetts
$11.9M +$1.39M +49,870 +13%
CCP
11
Clough Capital Partners
Massachusetts
$10.9M +$5.5M +196,903 +93%
BlackRock
12
BlackRock
New York
$9.25M +$9.38M +335,992 +90,078%
Vanguard Group
13
Vanguard Group
Pennsylvania
$4.23M +$211K +7,550 +5%
State Street
14
State Street
Massachusetts
$3.29M +$121K +4,331 +4%
Northern Trust
15
Northern Trust
Illinois
$2.74M +$60.1K +2,153 +2%
OM
16
Opaleye Management
Massachusetts
$2.15M +$2.19M +78,300 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$2.1M +$94.9K +3,397 +5%
Jennison Associates
18
Jennison Associates
New York
$2.07M – – –
EU
19
Emory University
Georgia
$2.02M +$488K +17,469 +31%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$862K +$7.79K +279 +0.9%
Charles Schwab
21
Charles Schwab
California
$845K +$52.5K +1,881 +7%
MWNA
22
Marshall Wace North America
New York
$835K +$833K +29,822 New
TCIM
23
TIAA CREF Investment Management
New York
$536K -$43.1K -1,544 -7%
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$402K -$16.8K -600 -4%
TA
25
Teachers Advisors
New York
$360K – – –
1
2 3

WVE Hedge Fund Activity: Q1 2017 in Review

49 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2017, worth a combined $432M — up 11% from $388M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new WVE positions and 5 closed out — a net gain of 2 holders — while 19 added to existing stakes and 13 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $9.61M. The largest seller was Fidelity Investments, cutting an estimated $2.75M.

  • 49 institutional investors held Wave Life Sciences (WVE) as of Q1 2017, down from 51 in Q4 2016.
  • Funds reported $432M of Wave Life Sciences stock for Q1 2017, up 11% quarter-over-quarter.
  • 7 funds opened new Wave Life Sciences positions in Q1 2017 and 5 closed out, a net change of +2 holders.
  • The largest Wave Life Sciences buyer in Q1 2017 was T. Rowe Price Associates, an estimated $9.61M added.
  • The largest Wave Life Sciences seller in Q1 2017 was Fidelity Investments, an estimated $2.75M sold.

Based on aggregated 13F filings for Q1 2017.